GSA Capital Partners LLP Purchases New Holdings in Cardinal Health, Inc. $CAH

GSA Capital Partners LLP bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,929 shares of the company’s stock, valued at approximately $1,171,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CAH. Vanguard Group Inc. raised its stake in shares of Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after buying an additional 617,775 shares in the last quarter. State Street Corp increased its stake in Cardinal Health by 1.8% in the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after acquiring an additional 221,497 shares during the period. Geode Capital Management LLC raised its position in Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP lifted its stake in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares during the period. Finally, Norges Bank acquired a new stake in Cardinal Health during the fourth quarter valued at approximately $790,344,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

CAH opened at $235.68 on Tuesday. The company has a market cap of $54.81 billion, a price-to-earnings ratio of 32.60, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. The firm has a 50 day simple moving average of $230.93 and a 200 day simple moving average of $217.34. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion for the quarter, compared to analysts’ expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s payout ratio is presently 28.49%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Weiss Ratings upgraded Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research note on Wednesday, August 5th. Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. TD Cowen boosted their price target on Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a research note on Thursday. Barclays upped their price target on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, Leerink Partners set a $292.00 price objective on Cardinal Health in a research note on Tuesday, August 11th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $265.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.